We build trusted, independent analysis at the intersection of AI and the life sciences — and turn a world-class niche audience into a media and intelligence business.
WTMB Research & Media is an institutional media and intelligence brand at the intersection of AI, technology, and life-sciences R&D — the moment that intersection is exploding. Our defensible edge is a distinctive, trusted analytical lens on the digitization of drug discovery, pharma, and healthcare.
We are deliberately not a daily breaking-news operation, and not a vendor directory. Commodity news is being erased by AI search; a dry catalog competes with databases that beat us on comprehensiveness. Instead, our website is permanent, definitive analysis, our newsletters are the weekly synthesis, and LinkedIn carries the fast, high-velocity takes. The institution is the container; named analyst voices are the contents.
As AI reshapes how medicines are discovered and developed, decision-makers are drowning in noise. Our mission is to be the analytical layer that turns that noise into judgment — for the people building, funding, and scouting the future of the field.
Analysis that serves the reader, kept clearly separate from commercial sponsorship.
A point of view built on a decade of tracking this space — not press-release syndication.
Definitive, permanent analysis written to be understood, not to chase clicks.
Work cited by governments, consultancies, and the leading press.
Leads editorial and analysis. PhD in Physical Chemistry and over a decade tracking the intersection of technology and life sciences.
Meet the analyst →
A network of named analyst and contributor voices extending the brand's coverage across the techbio landscape.